Your one-stop Solution for MEDICAL LEARNING & UPDATES

hidoc_medibot hidoc_medibot

Today's Updates

Solengepras Meets Primary Endpoint in Phase 3 ARISE Trial of Parkinson Disease Marco Meglio

Published Date: 12 Oct 2026

Phase 3 ARISE trial results show solengepras 150 mg significantly reduced OFF time and improved motor and non-motor symptoms in Parkinson disease.

Upadacitinib Feasible for Palmoplantar Pustulosis: David Gleeson, BM BCH David Gleeson, BM BCH

Published Date: 12 Oct 2026

Gleeson discusses JAKPPPOT data showing the therapy met all feasibility thresholds with a markedly larger response than historic placebo in PPP.

Nemolizumab Sustains Atopic Dermatitis Skin, Itch Control Through 3 Years

Published Date: 12 Oct 2026

Nemolizumab Sustains Atopic Dermatitis Skin, Itch Control Through 3 Years

Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism

Published Date: 12 Oct 2026

Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism

Knowledge Hub

Oncology

Fertility Preservation Considerations Before Hematologic Cancer Therapy 

Comprehensive review of fertility preservation strategies before hematologic cancer therapy for healthcare professionals.

Oncology

Digital Specimen Tracking for Precision Oncology Workflows 

Comprehensive review of digital specimen tracking systems in precision oncology workflows for improved diagnostic accuracy and patient safety.

Oncology

Wearable Sensors for Detecting Early Lymphedema Changes 

Comprehensive review of wearable sensor technology for early detection of lymphedema in clinical practice.

Oncology

Toxicity Surveillance for Bispecific Cancer Therapies 

Comprehensive review of toxicity surveillance strategies for bispecific cancer therapies in clinical practice.

Oncology

Case-Based Learning: Cancer-Associated Thrombosis During Noncytotoxic Therapy

Oncology

Pharmacokinetic Optimization of Combination Cancer Therapy

Oncology

Monitoring Delayed Toxicity of Antibody Therapies

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Dr. Harish P and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

Dr. Vijay Agarwal and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Dr Suvir Singh

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

Dr. Harish P and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Dr Suvir Singh

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

Dr Vijay Agarwal and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Dr Suvir Singh

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Dr. Todd Bauer and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Dr. Poonam Patil and 1 more

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot